TransMedics Group, Inc. (TMDX) Q3 2019 Earnings Results

TransMedics Group Misses on EPS, Stock Down 10.85%

TransMedics Group's earnings report showed a loss per share of $0.39, with no revenue figures disclosed. The stock dropped 10.85% following the report, reflecting investor concerns over the lack of financial guidance and clarity on future performance. The management's defensive tone suggests that the company is facing challenges that could impact its growth trajectory in the near term.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.39	N/A	N/A
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed a cautious outlook, emphasizing the importance of strategic initiatives. They acknowledged the challenges faced in the quarter.

Management did not provide specific revenue figures or guidance for the upcoming quarters.

The focus remains on long-term growth despite current challenges.

TransMedics Group Misses on EPS, Stock Down 10.85%

Key numbers

Management commentary

TransMedics Group, Inc.

More earnings this week

TransMedics Group Misses on EPS, Stock Down 10.85%

Key numbers

Management commentary